selected scholarly activity
-
conferences
- An Innovative Point of Care Tool to Implement the 2017 GOLD Report in Practice. American Journal of Respiratory and Critical Care Medicine. 2018
- Does OTC Orlistat Use Affect the Pattern of Physician Visits?. Obesity. S108-S109. 2009
- High Blood-Pressure Control Rates with an Antihypertensive Regimen Including Trandolapril in a Canadian Real-Life Clinical Practice Setting. Kidney and Blood Pressure Research. 327-327. 2009
- Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension - a TRAIL subanalysis. Journal of Hypertension. S466-S466. 2008
- Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension - A trail subanalysis. Canadian Journal of Cardiology. 86C-87C. 2007
- TRAIL - the effectiveness of trandolapril based treatment regimen in reaching blood pressure goals: An observational study. Journal of Hypertension. S41-S41. 2006
-
journal articles
- Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study. Canadian Journal of Diabetes. 47:398-404. 2023
- Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study. Canadian Journal of Diabetes. 47:345-351. 2023
- Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18–49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors. Human Vaccines and Immunotherapeutics. 19:2177066. 2023
- Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:214. 2022
- Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial. Translational Psychiatry. 12:101. 2022
- Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY). Open Forum Infectious Diseases. 9:ofab605. 2022
- Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine. Pediatrics. 147:e20194035. 2021
- L’obésité chez l’adulte : ligne directrice de pratique clinique. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E1757-E1775. 2020
- Obesity in adults: a clinical practice guideline. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E875-E891. 2020
- Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study. Journal of Electrocardiology. 58:56-60. 2020
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 391:205-218. 2018
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 391:219-229. 2018
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 377:1319-1330. 2017
- The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. Journal of the American College of Cardiology. 69:777-785. 2017
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. The Lancet. 389:1399-1409. 2017
- Effectiveness and Tolerability of a Trandolapril-Based Antihypertensive Treatment Regimen over 12 months in Actual Clinical Care Across Canada. Clinical Drug Investigation. 33:535-543. 2013
- Weight management experiences of overweight and obese Canadian adults: findings from a national survey. Chronic Diseases and Injuries in Canada. 32:63-69. 2012
- Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting. Advances in Therapy. 28:789-798. 2011
- Facilitating Access to Evidence-Based Weight Management in Canada: A Consensus. Canadian Pharmacists Journal. 143:140-144. 2010
- Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada. Current Medical Research and Opinion. 25:1379-1384. 2009
- A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Clinical Therapeutics. 29:305-315. 2007
- Resource Use Study in COPD (RUSIC): A prospective Study to Quantify the Effects of COPD Exacerbations on Health Care Resource Use Among COPD Patients. Canadian Respiratory Journal. 14:145-152. 2007
- Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five‐Month Multicentre Canadian Study. Canadian Respiratory Journal. 10:427-434. 2003
- Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy. Journal of Human Hypertension. 15:763-770. 2001
- A critical pathway for electronic medical record selection.. Proceedings - AMIA . Annual Symposium. AMIA Symposium. 264-268. 2001